v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05212831 |
Full text link
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : July 16, 2023, midnight Source : ClinicalTrials.gov |
|
Contact
Last imported at : July 16, 2023, midnight Source : ClinicalTrials.gov |
Not reported |
Registration date
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
2022-01-28 |
Recruitment status
Last imported at : July 16, 2023, midnight Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Crossover |
Masking
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Long covid |
Inclusion criteria
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
inclusion criteria: ability and willingness to give written informed consent prior to any study-specific screening procedures and to comply with the requirements of the study male or female, aged ≥ 18 years of age diagnosed with long-covid patient self-reported concerns regarding cognitive functioning or recent diagnosis of covid-19 related cognitive impairment moca test scores ranging from 13 to 25/30 at screening oxygen saturation spo2 ≤ 93 % on fingertip pulse oximetry and/or < 60% on brain nirs, at rest or during effort and/ or 10% relative decrease in brain saturation during exercise as compared to baseline value at screening ability to perform exercise treadmill test at screening tolerability of pulsed oxygen (o2) therapy delivered by poc at screening willingness and ability to wear poc. |
Exclusion criteria
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
contraindication to the use of poc including allergy to cannula material pregnancy or planning to become pregnant during the study non-covid-related cause for cognitive impairment (such as parkinson's disease, multiple sclerosis, alzheimer's disease, stroke, brain tumor, or dementia) subjects with respiratory infection at screening or randomization and/or acute bronchitis requiring antibiotics at the time of randomization or expected during the treatment participation in other interventional clinical trial within 30 days of randomization or expect to participate in any other investigational clinical trial during the conduct of this trial subjects who should be excluded in the opinion of the investigator |
Number of arms
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Inogen Inc. |
Inclusion age min
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Aug. 6, 2022, 5 p.m. Source : ClinicalTrials.gov |
Canada |
Type of patients
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
Severity scale
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : July 16, 2023, midnight Source : ClinicalTrials.gov |
21 |
primary outcome
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
COVID-19 related brain hypoxia and peripheral oxygen saturation;MoCA test;Other neuropsychological tests;VO2max during cardiopulmonary exercise test |
Notes
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : Jan. 29, 2022, 11:30 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 2135, "treatment_name": "Portable oxygen concentrator", "treatment_type": "Gas inhalation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |